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Breast cancer is the leading cause of cancer related mortality in women. The estimated 
new cases and death for 2010 in the US for females were 207,090 and 39,840 and for men were 
1,970 and 390 respectively. Breast cancer cells contain cancer stem cells (CSCs), which 
represent less than 5% of the total cancer cell population, but accounts for continuous 
proliferation and growth. Breast cancer is highly metastatic and can spread to various parts of the 
body. Signaling through cell surface markers, including CD44/CD24/ALDH1 in breast cancer, 
pro-survival factors, including Hsp90 and other client proteins, angiogenic biomarkers and 
telomerase activity are essential for cancer cell renewal and could represent putative targets for 
inhibiting breast cancer cell development. The aim of this research was to determine the in vitro 
anti-carcinogenic property of ginger oil against breast cancer cells (MDA-MB-231). We 
investigated the inhibitory activity of ginger oil against the biomarkers that are essential for 
breast cancer cell viability or proliferation. Cells were incubated with vehicle (DMSO), or ginger 
oil at concentrations, 0.05% to 0.2% of the volume of the media for 72 h at 37 °C and 5% CO2.  
Ginger oil dose-dependently inhibited the viability and proliferation of breast cancer cells in 
vitro. The mechanism of breast cancer cell inhibition included induction of caspase-mediated 
apoptosis, cell cycle arrest, inhibition of Hsp90 and some of its client proteins, down-regulation 
of cell surface biomarkers, CD44/ALDH1 in breast cancer cells, inhibition of the biomarkers of 





CHAPTER 1: INTRODUCTION 
Interest in dietary bioactive compounds to prevent chronic degenerative diseases and 
enhance health arises from evidence supporting a role of these compounds in human health. 
Chronic degenerative diseases are of interest because there are no known cure for most of these 
diseases and currently available treatments usually only provides a temporary reduction of 
symptoms. Breast cancer as a chronic disease is a commonly identified cancer in female in both 
economically developed and developing country (Jemal and others 2011). There are various 
treatments approaches that have been aimed towards the treatment of the disease but the success 
rate of the chemotherapeutic drugs are reported to be low with high rate of recurrence and 
various side effects. 
  Natural compounds or dietary agents have been used as an important tool to treat cancer 
because of its low cytotoxicity and less adverse effects. Ginger because of its aroma and taste, 
has been used for culinary purposes from ages. It has also been reported in use for medicinal 
purpose for more than 2500 years. Ginger is found to be rich of bioactive compounds and 
various researches have been carried out to explore the beneficial property of ginger and its 
extracts (Grzanna and others 2005; Ali and others 2008; Sharma and others 1994). Essential oils 
of ginger are of interest because of its richness in various functional compounds, mostly 
terpenes; monoterpenes and sesquiterpenes, which gives the oil its biological activity(Daferera 
and others 2002). These bioactive compounds can either remain unmodified or undergo 
metabolic transformation into active or inactive derivatives and to fully understand the potential 
of ginger oil in human health requires an understanding of the effect of bioactive compounds in 




Our aim was to evaluate the effect of oil from ginger against breast cancer. The main 
objectives of this study were to: 
1) Determine the effect of ginger oil on the viability of breast cancer cells  
2) Determine the effect of ginger oil on induction of apoptosis in breast cancer cell  
3) Determine the anti-angiogenic activity of ginger oil in vitro using human coronary artery 
endothelial cells and hormone-independent breast cancer cells. 
4) Determine the effect of ginger oil on the replicative potential of breast cancer cells  
5) Determine the effect of ginger oil on expression of various signal transduction molecules 














CHAPTER 2: LITERATURE REVIEW 
2.1 Breast Cancer  
According to National Cancer Institute at the National Institute of Health, breast cancer is 
defined as, “Cancer that forms in tissues of the breast, usually the ducts (tubes that carry milk to 
the nipple) and lobules (glands that make milk). It occurs in both men and women, although male 
breast cancer is rare.” Breast cancer is the leading cause of cancer related mortality in women. 
The estimated new cases and death for women in 2010 in the US were 207,090 and 39,840 and 
for men were 1,970 and 390 respectively. 
The rate of breast cancer in female in developed countries like Northern Europe, 
Australia/New Zealand and North America, has been reported to be 2-5 times higher than in 
developing countries Asia and sub-Saharan Africa, as shown in figure 2.1 (Jemal et al. 2011). 
Some of the major causes of higher incidence of cancer are due to the adopted life-style of 
“westernized diets”, lack of physical activity, alcohol, smoking and many others.   
Different types of cancer originate from and maintained by a small population of cells 
within, which are known as cancer stem cells. They represent less than 5% of the total cancer 
cell population and these cells are also the key to breast cancer aggressiveness and lethality. . 
Cancer stem cells possess the ability of self-renewal and differentiation. This small population of 
cancer stem cells forms a bulk tumor by using several self-renewal and differentiation pathways 
and are resistant to chemo- and radiation therapy. Therefore efforts have been made to target 
these pathways in order to abolish the recurrence and resistant behavior of cancer stem cells 










Figure 2.1: Incidence and Mortality Rate of Breast Cancer (GLOBOCAN 2008) 
Breast cancer can metastasize to lymph nodes and distant organs from the primary site, 
which is usually the cause of death. As shown in figure 2.2, the data presented by Lee et al. 
suggests that the rate of metastasis of breast cancer cells to organs like lung, liver and bone are 
higher than to other different organs (Lee 1983).  Various treatment strategies for patients with 
breast cancer have been developed like, chemotherapy, radiation therapy, hormonal therapy or 
adjuvant therapy that target specific properties of cancer cells. These therapies increases the rate 
of survival along with increased long term side effects (Weigelt and others 2005). To progress in 
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search for cure of cancer requires understanding of the properties of cancer, which are briefly 
explained in section 2.2. 
 
Figure 2.2: Primary breast cancer cells metastasis to various distant organs (Lee 1983). 
2.2 Features of Cancer Cells 
Most cancer cells have similar characteristics present in a normal cell except that some of 
the cells signaling processes are highly up regulated while some of them are heavily down 
regulated. Causes of cancer can be inherited through genes or can be adapted due to several 
activities like exposure to carcinogens.  As biomarkers are defined as molecular, cellular, 
functional measurable parameters indicative of a particular genetic, epigenetic or functional 
status of a biological system (Ludwig and Weinstein 2005), cancer cell biomarkers, which are 
the property of tumor cells can be used for diagnosis, prognosis, staging and treatment. 
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As described by Hanahan and Weinberg, the characteristics of cancer cells can be listed 
in six different catagories as described below and also shown in figure 2.2: 
 
Figure 2.3: Six hallmarks of Cancer (Hanahan and Weinberg 2000). 
2.2.1 Growth Signals and Cancer 
 There are various soluble growth factors that are present in a cell, based on which cell 
function normally. Normal cells usually recognizes different kind of growth signals and respond 
accordingly, but cancer cells do not require those exogenous growth signals and can grow 
independent of the signal from the tissue environment. Cancer cells are able to synthesize most 
soluble mitogenic growth factors and positively respond to the signals. Some of the growth 
factors produced by cancer cells are platelet derived growth factor (PDGF) and tumor growth 
factor (TGF). Cancer cell being self-sufficient in growth signal is also explained by higher 
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expression of the receptors. Due to the high level of receptors present in cancer cell, even very 
low level of growth factors are detected, which usually would not be recognized in normal cells. 
For example in breast cancer cells, epidermal growth factor receptor (EGF-R) and Her2/neu 
receptor are overexpressed (Slamon and others 1987). 
 Normal cells have the property of obeying anti-growth signal whereas cancer cells resist 
anti-growth signals. Normally when cells receive anti-growth signal, they get into quescient 
stage or permanently lose their ability to proliferate, but cancer cells deregulate this phenomena 
by disrupting pRb proteins and mutating various proteins like p15 and p21 because of which the 
CDK-cyclin complexes become unresponsive and disregard the anti-growth signals (Zuo and 
others 1996). 
2.2.2 Apoptosis and Cancer 
Apoptosis is also called programmed cell death. It is a normal process that occurs during 
development of cell. When stimuli for death are received, cells undergo various morphological 
changes and die in a regular and controlled manner. When signals are received by cells, there are 
various pathways that are active in order to cause apoptosis. During early phase of apoptosis, 
there are families of proteins called caspases that are activated. These groups of proteins create a 
cascade that leads to cleavage or change in many structural proteins, nuclear proteins or enzymes 
eventually causing cell death.   
But in case of cancer, the process of apoptosis is uncontrolled. Cancer cell gain the ability 
of escaping apoptosis by mutating tumor suppressor genes like p53, overexpressing apoptotic-
oncogenes like bcl-2 and c-myc, and inhibiting pro-apoptotic proteins like Bax and cytochrome-
C.   
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2.2.3 Limitless Replicative Potential 
 Cancer cell acquire the property of dividing several times that results in uncontrolled cell 
growth. The property of uncontrolled cell division and duplication can be defined by two 
different processes; 
2.2.3.1 Cell Cycle  
Cell cycle maintains cell division and growth processes so as to maintain a balance 
between cell division and cell death.  In a eukaryotic cell, cell cycle is divided into four different 
phases: Gap1 (G1) phase or phase for preparation of DNA synthesis, Synthesis (S) phase or the 
DNA replication phase, Gap2 (G2) or the preparation for mitosis phase and Mitosis (M) phase or 
the dividing phase. The phase other than the M phase is also called the interphase. 
DNA of cell can undergo many physical or chemical attacks that can cause its damage. 
The source for DNA damage can be extrinsic or intrinsic. Damaged DNA causes cancer. In a 
normal cell cycle, cell containing damaged DNA goes through a process called DNA repair, 
apoptosis or can halt the progression of cell cycle. For the assurance of this process, various 
checkpoints are present in a cell cycle. But in case of cancer, there is deregulation of the cell 
cycle process, cell with damaged DNA skip the checkpoints of cell cycle and keep dividing and 
replicating (Paulovich and Hartwell 1995). 
2.2.3.2 Activity of Telomerase 
Telomerase is a reverse transcriptase enzyme responsible for protecting and lengthening 
the telomeric ends of DNA. It is normally active only in few types of normal cells like the stem 
cells, germ cells and proliferating cells, but its activity has also been recorded in cases of cancer.  
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Telomeres are the TTAGGG sequences of DNA that are present at the ends of the 
chromosomes. The function of telomere is to maintain the stability of the DNA. With each cell 
division, the length of telomeres shortens, and eventually it reaches a limit where the cell is 
directed to arrest or senescence. The natural process of telomere shortening is evaded by 
activation and up regulation of telomerase, which is found considerably in cancer cells. 
Telomerase is found to be very active in 90% of breast cancers and not in normal cells 
and therefore is a potential target for both prevention and treatment of breast cancer.  Breast 
cancer cells have very short telomeres and inhibitors of telomerase can have a significant effect 
on further shortening the cells causing growth arrest and cancer (Herbert and others 2001). 
2.2.4 Tissue Invasion and Metastasis 
 Cancer cells are can migrate to distant organs through blood vessels, seed there and grow. 
This property of cancer cell is because of their ability of activating various extracellular 
proteases like Matrix Metalloproteinase (MMPs) and inhibiting Tissue Inhibitors of 
Metalloproteinase (TIMPs), both are very important for tissue remodeling. In a healthy 
condition, there is always a balance between MMPs and TIMPs, which prevents the degradation 
of extracellular matrix (ECM) proteins. Over expression of MMPs is associated with degradation 
of tissues in many chronic inflammatory diseases like cancer. Process of metastasis and tumor 
growth is influenced by increase in MMPs activity (Tang and others 2005).  
In case of breast cancer cells only MMP-2 and MMP-9 are over expressed, which 
belongs to gelatinase group, Gelatinase A and Gelatinase B respectively and are responsible for 
tissue invasion, metastasis, and angiogenesis (Joyce and Pollard 2009). Cancer cells are also 
capable of altering the binding property of cadherins and cell adhesion molecules.   In the 
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process of migrating through the blood vessels they also evade the immune system by release of 
immunosuppressive compound. Therefore tissue invading and metastasizing property of cancer 
cells can be controlled by targeting the tissue degrading enzymes, inhibiting tumor angiogenesis, 
and making tumor cells immune sensitive (Grothey 2005). 
2.2.5 Tumor Angiogenesis 
Angiogenesis is the process of formation of blood vessels from pre-existing vessels. This 
process happens throughout the life starting from the embryo. Angiogenesis helps to recover 
different physiological defects in our body, like wound healing, but it can be dangerous too. 
There are two types of angiogenesis; Physiological and Pathological.  
Cases of pathological angiogenesis can arise due to enhanced or excessive angiogenesis 
in the system or due to impaired or decreased rate of angiogenesis. Reduced angiogenesis causes 
many non-healing wounds cases like gastric or oral ulcers, diabetic ulcers, impaired bone 
fracture healing and cardiovascular diseases like atherosclerosis, diabetes, and restenosis, and 
also dented nervous system causing Alzheimer disease, amytropic lateral sclerosis, and diabetic 
nephropathy. Some of the other diseases characterized by abnormal angiogenesis are Crohn 
disease, osteoporosis, hair loss, kin pupura, telangiectasia, nephropathy, neonatal respiratory 
distress, pulmonary fibriosis, and emphysema. On the other hand, high level of angiogenesis 
creates many diseases like hemangiomas, cancer, psoriasis, obesity, diabetic retinopathy, 
atherosclerosis, asthma, nasal polyps, rheumatoid arthritis, inflammatory bowel disease, and 
endometriosis (Dulak 2005).  
Basically a tumor cannot grow in size beyond 1-2 mm until it is supplied with nutrients 
and oxygen. For a tumor to gain its size and cancerous properties, angiogenesis plays a very 
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critical role. In order to supply itself with nutrients and oxygen, the tumor turns the angiogenic 
switch and begins to express growth factors such as vascular endothelial growth factors (VEGF) 
promoting formation of blood vessels and directional growth. Therefore, targeting angiogenic 
mechanism has been one of the important anti-cancer approaches.  
 
Figure 2.4: Angiogenic switch 
2.3 Current Approaches against Breast Cancer Cells and Associated Risks 
  Breast cancer is a frequently occurring chronic disease that is diagnosed in females. 
According to the statistics provided in 2008, breast cancer has been found to cause 23% of the 
total cancer worlwide and 14% of the cases has been reported to cause death (Jemal et al. 2011). 






o Monoclonal antibodies 
o Chemotherapeutic drugs 
o Hormonal Therapy 
 Radiation 
 Preventive chemotherapy 
 Dietary approaches 
2.3.1 Drugs against Breast Cancer 
There are various drugs that have been introduced to treat breast cancer. The problem 
related with the drugs provided is, their side effects to non-tumoral tissues. Some of them are 
listed below (Pegram and others 2004; Cuzick and others 2011): 













Table 2.1: Some of the side effects associated with mode of treatment 
Radiation therapy Chemotherapy Hormonal therapy 
Lymphodema Hair loss Stroke 
Fractures of breast bone Nausea, vomiting Blood clots 
Pain in heart muscles Anemia Uterine cancer 
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Effect on heart Change of taste  
Risk of cancer Fatigues  
Swelling of breast Weight gain  
Fatigue Cognitive dysfunction  
Cardiac weakness Peripheral neuropathy  
 Heart failure  
 Leukemia  
 
2.4 Functional Foods and Cancer 
Functional foods are foods containing physiologically-active components, which provide 
health benefits beside nutrition, when consumed on a regular basis (Hasler 1996). The Institute 
of Medicine's Food and Nutrition Board (IOM/FNB, 1994) has defined functional foods as "any 
food or food ingredient that may provide a health benefit beyond the traditional nutrients it 
contains" Dietary agents contain many bioactive compounds in them and had been effectively 
used as a source of traditional medicine. Profound interest in health-benefiting foods have 
initiated various research to recognize activity of functional foods against different chronic 
degenerative diseases like, cancer, heart disease, osteoporosis, arthritis, age related diseases and 
many other. This correlates with what Hippocrates said 2500 years ago as, “Let food be thy 
medicine and medicine be thy food”.  Epidemiological studies focusing on the mechanism of 
functional food against cancer have demonstrated that consumption of fruits and vegetables 




Figure 2.5: Molecular targets of cell cycle regulation in cancer cells in vitro and in vivo by 
dietary agents. Upward arrows (↑) indicate enhancement, and downward arrows (↓) 
indicate a reduction in the levels, or inhibition of the activity of the target 
molecules(Meeran and Katiyar 2008). 
 
Table 2.2: Dietary Agents against Cancer Stem Cells (Li and others ) 
Natural dietary 
compound 
Food origin CSC Elements of self-
renewal pathways 















Green tea   HBP1, β-catenin 
Resveratrol Grapes, berries, 
plums, and peanuts 





  β-catenin 
Piperine Black and long pepper Breast CSCs Wnt/β-catenin 
Vitamin D3 Fish, egg yolk, beef 
liver 




2.5 Ginger  
Zingiber officinale belongs to the family Zingiberaceae (Park and Pezzuto 2002). It 
originated in South-East Asia and now is well known around the world. Ginger plant is an 
herbaceous, rhizomatous, perennial plant, which is usually 2-3 feet tall and is found naturally in 
tropical and sub-tropical region. The rhizome part of the plant or the ginger is an aromatic, pale 
yellowish, thick lobed structure and possesses a pungent smell. Ginger is commonly used as a 
flavoring agent in food. It is usually used as a fresh paste, or in dried form or in slices. It has also 
been used in cosmetic and medicinal purposes and used as a herbal medicine in Ayurvedic and 
Chinese tradition (Ali et al. 2008). It is reported to be rich in anti-oxidant content and has been 
used as a medicine from ancient time as back as 2500 years (Grant and Lutz 2000). 
Table: 2.3 Molecular Target of Ginger in Cancer (Aggarwal and Shishodia 2006)  
Name Active compound  Molecular Target 
Ginger (Zingiber officinale) Gingerol 
Paradol 
↓TNF, ↓NFK-B, ↓AP-1, 
↓COX-2, ↓ODC, ↓iNOS, 
↓p38MAPK, ↓HIF, ↓VEGF, 
↑caspase-3, ↓Bcl2 
  
Ginger possesses its health-enhancing property because of the presence of the pungent 
compounds and the volatile compounds. The odor of the ginger is mainly due to the essential oil 
present (Ali et al. 2008). Gingerols, shogaols and paradols are some of the pungent compounds 




Figure 2.6: Non-Volatile Pungent Components of Ginger (Shukla and Singh 2007) 
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many diseases like arthritis, urinary infections, gastrointestinal disorders and pain. It is also an 
effective antiviral and antimicrobial agent and has potential to reduce diabetes mellitus, 
cardiovascular and gastric disorders (Shukla and Singh 2007).  
Hsu et al. have also demonstrated 6-dehydrogingerdione (DGE) as a major component of 
ginger that has its effect against breast cancer. It was found that DGE activated caspase, up 
regulated p21 level and down regulated cyclin B1, cyclin A, Cdc2, Cdc25C and thus arrested 
cells at G2/M phase and caused apoptosis (Hsu and others 2010).  6-gingerol, another component 
of ginger has been found to have negative effect on NF-κB activation, cell proliferation, and 
angiogenesis (Kim and others 2005) and also arrests cell cycle at G1 phase by downregulating 
cyclin D1 (Ippoushi and others 2003). 
2.6 Ginger Oil 
Ginger contains 9% of lipids or glycolipids and 5-8% of oleoresin (Chrubasik and others 
2005). The percentage of essential oil in ginger is 3%. Essential oils are also called volatile oil or 
ethereal oil and are the aromatic oily part that is usually obtained from various parts of plants 
like flowers, buds, seeds, leaves, stem, bark, herbs, twigs, fruits or roots. Oils from plant have 
been used as a traditional medicine from ages. According to Food and Drug Administration, 
ginger essential oil has been regarded as a GRAS (Generally Recognized as Safe) product under 
the Code of Federal Regulation (CFR) parts; 182.10 and 182.20. 
Aromatic plants contain terpenes; mostly monoterpenes and sesquiterpenes, which 
provide them their biological property. Terpenes have very good property of penetration because 
of which they have been used as drug penetration enhancers (Aqil and others 2007). The factors 
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that contribute to permeation capability of terpenes are its lipophilicity, size and chirality, degree 
of unsaturation, boiling point, and energy of vaporization. 
   Sesquiterpenes are the abundant one in the volatile oil of ginger, and consists of 
zingiberene, curcumene, farnesene, b-sesquiphenalbrene, and bisabolene. The flavor and taste of 
ginger is derived from the volatile components in it (Shukla and Singh 2007).  
Studies have been carried out to evaluate the composition of ginger oil. Lawrence et al. 
found 114 compounds in the volatile oil of ginger (Lawrence 1984). Nogueira de Melo et al. 
have found curcumene, beta-mycrene, 1,8-cineol, citral and zingiberene as the major component 
of ginger oil (Nogueira de Melo and others 2011).  
Anti-inflammatory, antinociceptive, and immunomodulatory properties of ginger oil has 
been demonstrated by Nogueira de Melo (Nogueira de Melo et al. 2011).  The experiment 
carried out by Sharma et al on arthritic rats has suggested that ginger oil contains anti-rheumatic 










Table 2.4: Classification of Terpenes on Basis of Isoprene Units 









Table 2.5: Classification of Terpenes on Basis of Their Chemical Composition 
Class Example 
Alcohols Linalool, geraniol 
Esters and alcohols Linalool, linalyl acetate, menthol, menthyl 
acetate 
Aldehydes Cinnamaic aldehyde, cinnamic aldehyde 
Ketones Carvone, thujone 
Phenols Eugenol, thymol 





CHAPTER 3: MATERIALS AND METHODS 
3.1 Ginger Oil (GO) 
To carry out this research, commercially available ginger oil was purchased from Sigma 
Aldrich. According to the data provided, the oil was all natural, kosher, halal grade and obtained 
by steam distillation. Zingiber officionale roscoe of China origin was the source of the oil and it 
could be tasted in concentration as low as 30 ppm. The boiling point of the oil was listed as 
254
o
C and density as 0.871g/ml at 25
o
C. 
3.2 Cell Cultures 
In this study, hormone independent MDA-MB-231(HTB-26) human breast cancer cells, 
which are ER
-
, p53 mutated and a model of more advanced stage breast cancer (Hsu et al. 2010) 
were used to model the molecular mechanism for the inhibitory effect of ginger oil against 
cancer.  
The cell line gets its name from M.D. Anderson-Metastatic Breast- 231. The cell line was 
obtained from American Type Culture Collection (ATCC) (Rockville, MD). MDA-MB-231 is an 
epithelial adenocarcinoma cells isolated from the breast of Homo sapiens and have adherent 
growth properties. They were sub-cultured as a mono-layer according to the instructions 
provided by ATCC.   
The MDA-MB-231 human breast cancer cell line was maintained in Dubecco’s Modified 
Eagle’s Medium (DMEM) containing 10% of fetal bovine serum (FBS), 15mM HEPES, and 




Figure 3.1: Morphology of MDA-MB-231 Cells 
3.3 Gas Chromatography-Mass Spectrometric (GC-MS) Analysis of Ginger Oil 
Gas Chromatographic analysis was performed with a Leco TOF GC/MS system equipped 
with an Agilent 6890 GC, under the following conditions: DB-5 capillar column (30 m X 
0.25mm, 0.25 μm) (J &W Scientific, Albany, NY) was used with a flow rate of 1.0 mL/min. 
Ginger oil was diluted 1:10 with dichloromethane.  One microliter injections were made in 
splitless mode at an injection temperature of 300 °C.  The GC oven was initially held at 50 ºC for 
one minute then increased at 3 ºC/min to 80 °C and then at a rate of 10 °C/min to 340 °C.   Data 
was collected from m/z 35 to m/z 1000 at 20 spectra per second.  
3.4 Cell Viability Assay  
3.4.1 MTS Cell Proliferation Assay 
Breast cancer cells (5x10
3
 per well) were seeded on 96-well plates. The cells were grown 
for 24 h prior to treatment. Ginger Oil was mixed with dimethylsulfoxide in a ratio of 3:1 and 
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ginger oil at concentration of 0.05%, 0.1%, 0.15% or 0.2% of the total volume of the media used 
were added to the cells. The cells were incubated for 24, 48 and 72 hours at 37
o
C in an incubator 
with 5% CO2. After incubation, cells were treated with the MTS reagent according to the 
protocol provided by the supplier, CellTiter 96 AQueous One solution (Promega, Madison, WI). 
The number of viable cells was directly proportional to the absorbance at 490 nm due to the 
reduction of formazan product from MTS. Absorbance was read in a BioRad Model 680 micro 
plate reader (Hercules, CA). Cell viability was presented in terms of percentage of control. The 
experiment was performed in triplicates.      
3.4.2 Caspase Assay for Apoptosis 
After performing cell viability assay, caspase assay was performed in order to determine 
the activity of caspase in the cells treated with ginger oil. Breast cancer cells MDA-MB-231, 
5X10
3
 cells were seeded in a 96 well plate and after 24 h cells were treated with vehicle 
(DMSO), ginger oil at concentration of 0.05% or 0.1% of the total volume of the media used. 
The plate was incubated for 72 hours and caspase-9 assay was performed using the Caspase-Glo 
9
RM
 (Promega, Madison, Wisconsin).  After incubation, luminescence was measured using, The 
Reporter™ Microplate Luminometer. Results were presented in terms of percentage of control. 
Each experiment was performed in triplicate. 
3.5 Cell Cycle Analysis 
Breast cancer, MDA-MB-231, 0.5x10
6 
cells were grown on T-25 flasks and were treated 
with vehicle and ginger oil at concentration of 0.05%, 0.1%, 0.15% or 0.2% of the total volume 
of the media used. After 72 hours of incubation, cells were trypsinized and suspended in PBS 
and counted using trypan blue. Cells (2x10
5
) were selected and centrifuged at 1000 rpm (200g) 
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for ten minute at room temperature. The supernatant was discarded and the cells were re-
suspended in 100ul of PBS and 900ul of 95% cold methanol. Methanol was added drop by drop 
to the pellet; the cells were vortexed and incubated for 30 min at 4
o
C.   
After incubation cells were centrifuged at 2000 rpm for 5 min at room temperature. Then 
methanol was removed making sure not to lose cells. After that cells were suspended in 450µl 
Phosphate Buffer Saline (PBS) (Santa Cruz Biotechnology, Santa Cruz, CA), 25µl RNAse 
(Roche Diagnostics, Indianapolis, IN) (500 µg/ml) and 25µl Propidium Iodide (Sigma-Aldrich, 
St. Louis, MO) (1mg/ml). The samples were incubated in dark for 24 hours and flow cytometric 
analysis was performed using Beckman-Coulter Epics flow cytometer using CXP software. 
3.6 In Vitro Angiogenesis 
The assay was performed using the in vitro angiogenesis assay kit from Millipore
TM
. Following 
the preparation of ECMatrix
TM 
using the manufacturer’s instructions, 7.5 x 10
3
 human coronary 
artery endothelial cells (HCAECs) were seeded on the surface along with the 150ul supernatant 
from the untreated MDA-MB-231 cells and cells treated with 0.05% and 0.1% ginger oil. The 
cells were then incubated at 37
o
C for 6 hours and tube formation was analyzed and photographed 
using a Leitz phase-contrast inverted microscope at 10X magnification.  
3.7 Telomerase Activity 
Telomerase is the enzyme responsible for adding the telomeric repeats at the end of DNA 
sequence. Its activity has been reported in immortal cells, cancer cells and germ cells. 
Telomerase activity in the samples was measured using a PCR based assay (TRAPEZE
®
 XL 
Telomerase Detection Kit, Millipore
TM
, Billerica, MA). MDA-MB-231 cells were first treated 
with ginger oil at concentration of 0.05% and 0.1% of the total volume of media used. After 72 h 
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of incubation, cells were lysed with CHAPS lysis buffer provided in the kit to extract the protein. 
Protein concentration determination of the lysate was done by Bradford method using BSA as 
standard. The concentration of the protein of the samples used for detection of telomerase was 
made to 750ng/µl. And then the protein samples were then combined with TRAPeze reagents to 
perform PCR. Manufacturer’s instruction was used for making the standards provided in the kit.  
As telomerase is a heat sensitive enzyme, negative telomerase samples were also 
prepared by heat treating them at 85
o
C for ten minutes. The primer provided in the kit is 
Ampifluor® primers that only glow after incorporation. After running the PCR, to quantitate 
telomerase activity, fluorescein and sulforhodamine emission detection was done using 
Cytofluor
®
 Multi-well Plate Reader (PerSeptive Biosystems, Framingham, MA). The excitation 
and emission filters for fluorescein detection was at 485nm and 535nm respectively. While for 
sulforhodamine detection, the excitation and emission filter was at 585 nm and 620 nm 
respectively. The reading was taken using fluorometer. The results were expressed in terms of 
percentage of control. The experiment was done in triplicates. 
3.8 Western Blot Analysis of Biomarkers 
MDA-MB-231 cells were incubated with varying concentration of ginger oil, 0.05% and 
0.1% of the volume of media for 72 hours. Cells were then washed with Phosphate Buffered 
Saline (PBS), lysed in radioimmunoprecipitation assay buffer (RIPA) supplemented with 
protease inhibitor, sodium orthovanadate and phenylmethanesulfonylfluoride (PMSF). After 30 
min incubation on ice with the lysis buffer, cells were centrifuged at 14,000 rpm for 10 min, and 
the supernatant was saved; protein concentration was determined by the Bicinchoninic acid 
(BCA) method using BCA protein Assay Reagents (Thermo Scientific, Rockford, IL). Equal 
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amounts (1000 μg) of total cell extract protein from control and GO treated cells were mixed 
with LDS sample buffer (Invitrogen, Carlsbad, CA), brought to desired volume with water, 
boiled for 3 minutes centrifuged at high speed for 30 sec, and loaded onto SDS polyacrylamide 
gels; 4-12% Bis-Tris gels or 3-8% Tris-acetate gels (Invitrogen, Carlsbad, CA) depending on the 
size of the protein.  
Proteins of interest were then separated and transferred to polyvinylidene difluoride 
(PVDF) membranes (Invitrogen, Carlsbad, CA). Membranes were
 
blocked with 5% Bovine 
Serum Albumin (BSA) in Tris Buffer Saline (TBS) containing 0.05% Tween 20 (TBS-Tween) 
for 1h. The PVDF membranes were incubated with primary antibody in TBS-Tween containing 
5% BSA overnight at 4 ºC with gentle agitation following the manufacturer’s instructions. 
Visualization of the bound primary antibody
 
was done by probing with alkaline phosphatase–
conjugated
 
secondary antibodies and exposure to chromogenic detection
 
reagent BCIP 
(Invitrogen, Carlsbad, CA).  
Primary antibodies like NF-κB, Cadherin E, Bax, Bcl2, CD44, ESA, Aldh1, VEGF, 
cathepsin D and the alkaline phosphatase- conjugated secondary antibody was purchased from 
Santa Cruz Bitechnology
® 
(Santa Cruz, CA). Other primary antibodies like Hsp90, PDGFR-β, p-




3.9 Interleukin-8 (IL-8) and Tumor Necrosis Factor-α (TNF-α) Levels in MDA-MB-231 
Cell Supernatants 
To determine the effect of inhibition by GO on IL-6, IL-8 and TNF-α expression, we 
measured their levels in the supernatants of vehicle, 0.05% and 0.1% GO treated cells by ELISA 
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using commercial kits from Prepotech (Rocky Hill, NJ). Manufacturer instructions were used 
and the test was done in triplicate and results were expressed in percentage of control.  
3.10 Statistical Analysis 
Results are expressed as means ± SD of experiments each conducted in triplicate. 
Statistical analysis was conducted using the Statistical Analysis Software (SAS) (version 9.2). 
Analysis of variance (ANOVA) was conducted to examine the differences between treatments 














CHAPTER 4: RESULTS AND DISCUSSION 
4.1 GC-MS Analysis of Ginger Oil 
To determine the components of the ginger oil GC-MS analysis of the oil was done. 
Trace level of compound present were detected and all of those compounds are presented in 
Table 4.1. Among those many compounds present in ginger oil, the major compounds were 
eucalyptol (14.2%), cuparene (12.3%), bicycloheptane (11.4%), γ-muurolene (10%), α-farnesene 
(8%), α-pinene (4%), and β-myrcene (2.2%). However the level of zingiberene, curcumene and 
citral were found to be as low as 0.7%, 0.2% and 0.4%, which contrasts with the findings of 
Nogueira de Melo et al., who had reported ar-curcumene, beta-mycrene, 1,8-cineol, citral and 
zingiberene as  the major component (Nogueira de Melo et al. 2011).   
The effect of sesquiterpenes has been studied in many tumor cell lines. Cadinol and γ-
muurolene exhibit anti-cancer effect on colon cancer and breast cancer cells (Chang and others 
2000). And the results from GC-MS analysis shows that ginger oil contains both cadinol, γ-
muurolene at concentrations of 0.1% and 10.9% respectively.  Elmene, which is also one of the 
components found in ginger oil, also has been studied for its anti-tumor activity in leukemia 
cells. The results found from the study by Yang suggest that elmene is effective in inducing 
apoptosis, which gives property of anti-tumor activity to it (Yang and others 1996) 
Essential oils from berries, Schinus molle L. and Schinus terebinliflious have been shown 
to have anti-cancer properties against breast cancer cells (Bendaoud and others 2010), and some 
of the compounds of the oil were similar to the one found in ginger oil like, germacrene D, 
terpinoid, phellandrene, pinene, cymene, terpineol, and α-himachalene. This suggests that 
properties of ginger oil against cancer are due to the presence of all these bioactive molecules. 
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α-Pinene 4.0 Cyclohexene 1.2 
Bicyclo[4.1.0]heptane, 7-(1-methyl  
ethylidene)- 
11.4 α-Copaene 0.9 
β-Pinene 0.4 β-Elemene   1.9 
β-Myrcene 2.2 Zingiberene 0.7 
l-Phellandrene 0.9 Germacrene D 0.6 
Eucalyptol 14.2 Germacrene B 2.1 
α-terpinolene 0.4 β-Sesquiphellandrene 2.0 
3-Methyl-2-(2-methyl-2-butenyl)-
furan 
0.5 neoalloocimene 0.6 
Linalool 0.8 (R)-Cuparene 12.3 
m,/z 168 Me Borneol Ether 0.2 α-Farnesene 8.0 
m/z 136 & 154 Terpenoid 0.1 alpha-Himachalene 4.8 
Camphor 0.1 γ-Muurolene 10.9 
exo-methyl-camphenilol 0.1 α-Farnesene  2.5 
Rose furan epoxide 0.5 Camphogen 0.2 
1-borneol 1.7 Sesquisabinene 
hydrate 
0.8 
4-Terpineol 0.2 α-curcumene 0.2 
α-Terpineol 1.1 Zingiberenol 1.1 
n-Decanal 0.3 α-Gurjunene 1.0 
β-Citronellol 0.3 Bicyclogermacrene 0.6 
Z-Citral 0.2 τ-Cadinol 0.1 
GERANIOL 0.5 β-Eudesmol 1.9 
E-Citral 0.4 α-cedrane 0.9 
l-Bornyl acetate 0.3 Mint sulfide 0.3 
2-Undecanone 
 
0.4 Nerol 0.3 







4.2 Effect of Ginger Oil on Cell Viability  
To determine the number of viable cells after the treatment with ginger oil, cell 
proliferation assay was performed using CellTiter96® Aqueous from Promega (Madison, 
Wisconsin). The assay is based on the colorimetric principle to determine the number of viable 
cells. After adding MTT reagent into the cells, formazan product is formed from the tetrazolium 
salt containing MTT reagent. The formazan is an aqueous soluble, colored product formed from 
the mitochondrial activity of the viable cells and is read at 492 nm. The absorbance at 492 nm is 
directly proportional to the number of viable cell present (Malich and others 1997). This assay 
has been used to quantitate cell proliferation and survival of living mammalian cells (Mosmann 
1983).  
To investigate the effect of ginger oil on the growth of MDA-MB-231 breast cancer cells, 
cells were incubated for 24h, 48h and 72h with 0.05%, 0.1%, 0.15%, and 0.2% of ginger oil with 
respect to the volume of media used for cell growth. Cell proliferation was then measured at 
490nm using MTS assay. As shown in figure 4.1, cell growth was reduced only by 1%, 5%, 9%, 
and 26% in the cell treated with 0.05%, 0.1%, 0.15%, and 0.2% of ginger oil for 24 h. But after 
48 h, cell growth was reduced by 20%, 26%, 40%, 60% in terms of 100% of control with 0.05%, 
0.1%, 0.15% of ginger oil and 72 h of incubation caused reduction of 52%, 61%, 66%, and 73% 
Literatures suggest that [6]-gingerol, one of the major compounds of ginger is able to 
inhibit growth and proliferation of colon cancer cells at a concentration of 100µM/L (Jeong and 
others 2009).  Other group of study has shown that after 72 h incubation of [6]-gingerol in 
colorectal cancer cell, the rate of cell growth was reduced by 22% and 28% with 150µM and 
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200µM [6]-gingerol respectively. The growth was also reduced in CaCo2 and HT-29 cells by 8 
and 28% respectively (Lee and others 2008). 
 
Figure 4.1: Effect of Ginger oil on the viability of MDA-MB-231 cells with respect to time and 
concentration. Values (means ± SD, n=3) not sharing common letters, ABCDE are 
significantly different (α=0.05). 
4.3 Effect of Ginger Oil on the Activity of Caspase for Apoptosis 
To further evaluate the cause of apoptosis, caspase assay was performed by determining 
the caspase activity on the cells with vehicle and ginger oil treated cells, Caspase-Glo®-9 Assay 
from Promega was used. Caspases are group of proteases that plays a very important role in the 
process of apoptosis in mammalian cells. This caspase assay is a luminogenic assay that 
measures the caspase activity. The reagent provided includes substrates for caspase activity, 

















































substrate; this cleavage causes the release of glow, which is measured as a luminescent signal. 
The amount of luminescence is directly proportional to the activity of caspase in the system. 
As shown in figure 4.3, our results demonstrated that the activity of caspase in the cells 
treated with ginger oil was higher than in control. In case of the cells treated with 0.1% ginger oil 
the level of caspase activity was significantly increased as high as 136% more than the control. 
Activated caspases can cleave various intracellular proteins, protein kinases, molecules 
for DNA repair and many components of nucleus and cytoplasm. This process leads to 
interference of the survival pathways and creates many morphological and biological changes, 
which causes apoptotic cell death (Earnshaw and others 1999).  
 
Figure 4.2: Pathway of Caspase Activation.(Nunez and others 1998) 
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Among various caspases, caspase8, caspase9, and caspase10 act as an initiator caspase 
that can trigger the activation of different other caspases. Caspase 9 is a type of caspase that is 
activated by mitochondrial initiated pathway. This creates a series of caspase cascade that 
ultimately destroys cell (Chen and Wang 2002).  This caspase is responsible for a chain of 
caspase cascades. It activates downstream caspases like caspase -3, -6 and -7 (Budihardjo and 
others 1999). 
 
Figure 4.3: Dose Dependent Effect of Ginger Oil on the Activity of Caspase9. Values (means ± 
SD, n=3) not sharing common letters, ABC are significantly different (α=0.05). 
4.4 Ginger Oil Modifies Breast Cancer Cell Cycle Progression and Cell Cycle Regulatory 
Protein Expression 
To determine the effect of ginger oil on the cell cycle and to confirm apoptosis, cell cycle 
analysis of the cells treated with vehicle and 0.05% or 0.1% of ginger oil was done by flow 




























sub-G1 phase formation in MDA-MB-231 breast cancer cells. The results from cell cycle 
analysis showed that ginger oil treatment resulted in the increase of sub-G1 phase. The 
percentage of the cells in sub G1 phase of the vehicle was 1.83% and in those treated with 0.05% 
or 0.1% of ginger oil was 14.80% and 69.19% respectively.  
During apoptosis, the DNA of the cell undergoes degradation due to many enzymes. To 
analysis this phenomenon, DNA analysis can be done. The sub G1 phase of the cell cycle 
provides the percentage of those cells with damaged DNA. When the cell loses the DNA, the cell 
stains less and then appears at the left side of the G1 phase, that is why it is called the sub-G1 
phase (Kajstura and others 2007). 
Cell cycle analysis also demonstrated that ginger oil treatment resulted in an increase of 
the G2 phase and S phase. G2 phase of the cycle showed that the control had 15.98% cells, 
0.05% GO treated cells had 20.86% cells, and 0.1% GO treated cells had 17.68% cells. The S 
phase and decrease of the G1 phase of the cell cycle in MDA-MB-231 cells. Ginger oil increased 
the cell cycle arrest at G2 and S phase. 
To determine the level of cell cycle regulatory proteins, western blot analysis of some of 
those proteins was done. Cyclin dependent kinase and cyclin proteins; Cyclin D1, CDK-4, and 
CDK-2 proteins were analyzed. Cyclin dependent kinase and cyclin are responsible for the 
transition from G1 to S phase. As shown in figure 4.4, ginger oil effectively decreased the 
expression of cyclin D1, CDK4 and CDK2 required for G1 progression. 
Cyclin dependent kinase (CDK) and cyclin proteins are the one responsible for the 
transition from G1 to S phase. Cell cycle is regulated by the phenomena of activation and 
deactivation of these CDK and cyclin complexes. There are elven different kinds of CDKs 
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identified in cells of mammals, which are CDK1-CDK11, but only CDK2, CDK3, CDK4, and 
CDK6 make a complex with G1 cyclins and are responsible for the transition from G1 phase to 
the S phase. Checkpoint proteins checks for DNA damage, causes cell cycle arrest, and sends 
signals to the other cascade mechanisms like cell cycle repair or apoptosis. Dysregulation of the 
checkpoint process in a cell may result in cardiovascular diseases, neurodegenearative disorders, 
cancer, and many others. 
CDK4 and CDK6 are activated during mid G1 phase and complexes with cyclin D while, 
CDK2 complexes with cyclin E and cyclin A during late G1 phase (Morgan 1997). CDK2 has 
also been reported as a potential target for treatment of breast cancer at early stage. Cyclin Ds in 
the G1 phase are activated as soon as cells enter the cell cycle, and the complex passes signals 
for mitogenic pathways. Cyclin D1 independent of CDKs also interacts with histone acetylase 
and other transcription factors (Diehl and others 1998). Cyclin E controls the beginning of DNA 
replication and the CDK2/cyclinE complex also prompts the duplication of centrosomes. Cyclin 
E is found to be overexpressed in cases of lungs cancer and breast cancer. Cyclin A assists in 
assembling the components for DNA synthesis and hence activates the S phase and at the same 
time it also makes sure that no other new complexes are assembled so it assures G1 phase has 
ended before the beginning of the S phase (Coverley and others 2002). 
Besides triggering the mechanism for repairing DNA damage, CDK-cyclin complexes 
are also supposed to maintain or regulate the length of telomeres and structure of chromatin, 
controlling transcription of DNA repairing genes, arranging cytoskeleton and staffing repairing 
proteins to the site. If the checkpoints fail to detect the damage, it may lead to various 
abnormalities like mutation, aneuploidy and chromosome instability, which eventually leads or 











         
 
 
Figure 4.4: Cell Cycle Analysis of A: Control cells, B: Cells Treated with 0.05% GO, C: Cells 


















1±0.008   0.36±0.002   0.32±0.010  
1±0.003   0.39±0.016   0.32±0.010  
1±0.009   0.90±0.005   0.89±0.004  

















4.5 Effect of Ginger Oil on Tumor Necrosis Factor-α (TNF-α) Levels 
To determine the level of TNF-α expression in the treated cells ELISA was done. TNF- 
α, a pro-inflammatory cytokine is a peptide hormone that effects death of tumor cells, 
inflammation and immune response. Our in vitro experiments show that ginger oil can inhibit the 
proliferation of MDA-MB-231 breast carcinoma cells. As shown in figure 4.5, ginger oil can 
significantly inhibit the expression of TNF-α at concentrations of 0.05% and 0.1%.  
TNF-α was primarily discovered as a molecule responsible for antitumor activity, but 
recent studies have proved that this molecule facilitates tumor initiation, promotion, and 
metastasis. Increase in TNF-α level increase the property of tissue invasion and metastasis 
through the up regulation of NF-κB pathway (Hagemann and others 2005). TNF- α secreted by 
tumors induce the secretion of matrix metalloproteases (MMPs) that help in the process of 
invasion and metastasis, and also increases the production of VEGF (Szlosarek and Balkwill 
2003). Inflammation is one of the major properties required for promotion of tumor. Among all 
the cytokines responsible for cell-cell communication, TNF- α is a major one. The 
proinflammatory effect of TNF- α is primarily because of its capability to activate NF-κB, which 
further causes expression of many inflammatory genes. 
Hanahan and Weinberg have classified cancer with six different major hallmarks and 
they have also reported that chronic inflammation is caused by the dysregulation of TNF- α 
production. TNF-α promotes carcinogenesis by influencing all six hallmarks of cancer. It does so 
by activating reactive oxygen intermediates (ROIs) that in turn activates telomerase giving it 
limitless replicative potential, by up regulating inflammatory enzyme like; nitric oxide synthase, 
cyclo-oxygenase, by triggering the production of matrix metalloproteases responsible for 
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invasion and metastasis, and by activating many other cytokines and cell adhesion molecules 
(Hanahan and Weinberg 2000; Szlosarek and others 2006).  
TNF- α is found to be a growth factor for most of the tumors including breast cancer. As 
TNF can mediate so many pathways for carcinogenesis, it has been a potential target for therapy 
against various chronic diseases. Various dietary phytochemical agents have been reported to 
decrease the level of TNF- α expression; curcumin, green tea polyphenols, resveratrol, 
kaempferol, apigenin, and gingerol (Yang and others 1998; Surh and others 1999; Kowalski and 
others 2005). 
 
Figure 4.5: Effect of Ginger Oil on the Expression of TNF-α. Values (means ± SD, n=3) not 







































4.6 Inhibition of Telomerase Activity  
Telomerase are found to be active in cancer cells and dormant in normal cells. 
Telomerase gives cancer cells its property of immortality. Also high telomerase activity 
correlates with high malignancy and aggressive nature of cancer. Therefore telomerase has been 
a potential target against cancer. As shown in figure 4.6, we have demonstrated that ginger oil at 
concentrations of 0.05% and 0.1% could significantly inhibit telomerase expression by 21 % and 
49% respectively in compare with the control. 
Researches have shown that ethyl acetate extraction of ginger down regulates the 
expression of human telomerase reverse transcriptase (hTERT) gene eventually decreasing the 
level of telomerase in lung cancer cells (Tuntiwechapikul and others 2010). Some of the other 
sources of dietary agents that have been able to inhibit telomerase are polyunsaturated fatty acids 
like eicosapentanoeic acid and docosahexaenoic acid(Eitsuka and others 2005), epigallocatechin 
gallate from green tea (Naasani and others 2003), sulfoquniovosyldiacylglycerol from plants and 
seaweed (Eitsuka and others 2004), sulforaphane from broccoli (Moon and others 2010). 
4.7 Effect of Ginger oil on Expression of Various Signal Transduction Molecules 
To determine the effect of ginger oil on different signal transduction pathways, 
expression of proteins that are over expressed in case of breast cancer were investigated. There 
are various signaling proteins that are activated for the proliferation and anti-apoptotic property 
of cancer cells. Therefore molecules that are involved in different processes of cell regulation 






Figure 4.6: Effect of Ginger Oil on the Activity of Telomerase. Values (means ± SD, n=3) not 
sharing a common letters, ABC are significantly different (α=0.05). 
4.7.1 Effect of Ginger Oil on Expression of Oncogenic Proteins 
4.7.1.1 Nuclear Factor-KappaB (NF-κB)  
Expression of NF-κB supports the cell to proliferate and survive however down regulation 
of this protein molecule directs cell towards apoptosis (Aggarwal and others 2004). As shown in 
figure 4.7, the results from the western blots show that there was down regulation of NF-κB by 
ginger oil at concentrations, 0.05% and 0.1%. This can also be supported by the findings of 
Aggarwal that gingerol from ginger down regulates NF-κB pathway (Aggarwal and Shishodia 
2006). Some of the genes that regulate NF-κB are bcl-2, survivin, TRAF 1 and TRAF 2 and they 
act by blocking the apoptotic process so these genes and proteins are highly expressed in cancer 
(Aggarwal and Shishodia 2004). The treatment of cancer cells with ginger oil also showed to 







































High activity of NF-κB activity is also associated with high level of VEGF mRNA 
expression, which means that inhibition of NF-κB, should lead to inhibition of VEGF production 
(Shibata and others 2002).  Our results (Figure 4.12) also demonstrate that cells treated with 
ginger oil shows significant decrease in VEGF levels. 
4.7.1.2 Heat Shock Protein 90 (Hsp90)  
Heat shock response is a very important property that cancer cells possess and Hsp90 is 
one of the very important molecular chaperones involved in this response. Hsp90 is a master 
regulator that gives activity and stability to many oncoproteins like Her2, many kinases and 
transcription factors. It is overexpressed in cancer cells and in case of breast cancer; it is 
associated with decreased survival (Pick and others 2007). Oncoproteins undergo several 
mutations and this phenomenon makes them resistant to inhibitors and for cases like this, 
targeting Hsp90 might be a useful solution as many oncoproteins depend on Hsp90 to maintain 
their oncogenic property and mutations (Porter and others 2010).  
As shown in figure 4.7, we could demonstrate that Hsp90 expression level was reduced in 
cells that were treated with ginger oil at concentrations of 0.05% and 0.1%. The reduction was 
from 15% to 18% compared to the control. 
4.7.1.3 E Cadherin 
Cadherins are the calcium ions dependent transmembrane glycoproteins responsible for 
cell adhesion. Breast E Cadherin is expressed in normal epithelial cells of breast and the reduced 
expression of E cadherin has been found to induce the property of invasion and metastasis in 
breast cancer (Oka and others 1993; Siitonen and others 1996). As shown in figure 4.7, E 




Figure 4.7: Expression of Oncogenic Proteins 
4.7.2 Effect of Ginger Oil on Expression of Growth Factor Receptors 
In case of pathological conditions like cancer, growth factors are highly expressed. This 
makes cancer cell very sensitive even to very a lesser amount of growth signals. As shown in 
figure 4.8, the expression of PDGFR-β, p-IGF-1R or Her2 was highly down-regulated in cells 
treated with ginger oil at both concentration of 0.05% or 0.1%. 
4.7.2.1 PDGFR-β 
Platelet derived growth factors (PDGF) are secreted by endothelial cells for the formation 
of blood vessels in mammals (Hoch and Soriano 2003). These growth factors further activate 















 E Cadherin 
 
β-actin 
1±0.035     1±0.009     1±0.039 
1±0.004     0.71±0.034     0.26±0.039 
1±0.004     0.85±0.002     0.82±0.038 
0.63±0.003  0.83±0.002   1±0.001          
Control     GO0.05%    GO0.1% 
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important functions in process of embryogenesis but its over-expression has been found in many 
pathological diseases like cancer (Carvalho and others 2005).  
4.7.2.2 p-IGF-1R 
 Insulin-like growth factor 1 receptor is found in phosphorylated condition in all breast 
cancer and accounts for poor survival. IFF-1R is a receptor tyrosine kinase that is considered as 
oncogene responsible for proliferation, survival, transformation, cell to cell interactions, and 
differentiation. Expression of this receptor is fundamental for the process of metastasis and cell 
survival (Zhang and others 2011). 
4.7.2.3 Human Epidermal Growth Factor Receptor 2 (Her-2) 
As shown in figure 4.8, ginger oil dose dependently at concentrations of 0.05% and 0.1% 
inhibited the expression of Her-2, which is overexpressed in 25-30% of breast cancers. Its level 
is highly increased in malignant cell; it gives aggressive property to tumor. Her2 overexpression 
increases the aggressive form of the disease therefore there is less chance of survival of patients. 
4.7.3 Effect of Ginger Oil on Expression of Pro-Apoptotic, Anti-Apoptotic and Cell 
Survival Proteins 
 As shown in figure 4.9, ginger oil at concentrations of 0.05% and 0.1% of volume of 
media used, could increase the level of pro-apoptotic protein like Bax and at the same time 
ginger oil could drop the expression of anti-apoptotic protein like Bcl-2. Literature suggest that 
constituents of ginger, galanals A and B can successfully inhibit Bcl-2 and enhance Bax in case 
of leukemia (Miyoshi and others 2003). 
 P38/MAPK pathway regulates variety of cellular responses to stress and inflammation. 
Although p38 is considered as inducer of apoptosis and inhibitor of cell proliferation, very high 
expression of phosphorylated p38 is found to be associated with cell survival (Esteva and others 
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2004; An and others 2011). The level of phosphorylated p38 is considered to be very high in 
breast cancer (Mao and others 2010).  
 
Figure 4.8: Expression of Growth Factor Receptors 
As shown in figure 4.9, we have found out that ginger oil down regulates the expression 
of phosphorylated p38. Our outcomes are consistent with the observations made by others, where 
p38 MAPK activity modulated the regulation of several cytokines that included IL-8 and TNF-α. 
Researchers have shown that inhibition of p38 activation leads to strong inhibition of Tumor 
Necrosis Factor (TNF-α) and Interleukin-8 (IL-8) (Westra and others 2004), which strongly co-
relates with our findings presented in figure 4.5 and figure 4.13 respectively. Our results suggest 
that ginger oil can significantly inhibit the expression of this oncogene, phosphor-p38 at 




Figure 4.9: Expression of Proteins Involved in Apoptosis and Survival 
4.7.4 Effect of Ginger Oil on Expression of Cell Surface Biomarkers 
 Our results as shown in figure 4.10, demonstrate that ginger oil was effective against 
inhibiting breast cancer stem cell surface biomarkers like Aldh1/CD44/ESA. These data 
emphasizes the anti-carcinogenic activity of ginger oil against breast cancer stem cells. Aldh1 is 
a marker for normal and malignant human mammary stem cells. Curcumin and piperine have 
been reported to inhibit the expression of Aldh1, breast stem cell marker (Kakarala and others 
2010). Dietary agents like sulforophane in combination with drug has also been reported to 
inhibit Aldh1 (Kallifatidis and others 2011). CD44
+
 stem cells are found to be resistant against 
chemo- or radiation- therapy induced cell death (Takaishi and others 2009). Epithelial –specific 
antigen (ESA) is also expressed in breast cancer stem cells and all these biomarkers containing 
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breast cancer cells have very good self-renewal potential and are very aggressive with poor 
prognosis (Manson and others 2007). 
 
Figure 4.10: Expression of Cell Surface Markers 
4.8 Effect of Ginger Oil in Process of Angiogenesis 
4.8.1  Effect of Ginger Oil  on Endothelial Cell Tube Formation 
 To determine the effect of ginger oil in the process of angiogenic tube formation, in vitro 
angiogenesis kit from Millipore was used. The process of angiogenesis is a multi-step process 
and this assay gives the basis for studying the tube formation. The matrix provided in the assay 
resembles the basement membrane, and it contains the basement proteins that are required to 
form tube. Endothelial cells when place in the matrix, aligns in a way to form a hollow tube. To 
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test the inhibitory effect of ginger oil on tube formation, media of the cells untreated and treated 
with ginger oil was introduced to the seeded human coronary artery endothelial cells and the 
effect was observed after 6 hours. 
 The results of this experiment showed that in presence of ginger oil at concentrations as 
low as 0.05% and 0.1%, endothelial cells alignment was disrupted, which is presented in figure 
4.11. While the controls; one with only endothelial cells and the other with endothelial cell with 
the media from the untreated MDA-MB-231 cells were able to form highly organized, 
extensively aligned capillary-like structure. Researchers have been able to show that [6]-
gingerol, a pungent compound from ginger is able to inhibit VEGF induced endothelial cell 
proliferation and reduced the size of the tube in vitro and in vivo at a concentration of 10 µM 
(Kim et al. 2005). 
4.8.2 Effect of Ginger Oil on Expression of Angiogenic Biomarkers 
4.8.2.1 Vascular Endothelial Growth Factor 
 To support these results of in vitro angiogenesis, we also analyzed the expression of 
vascular endothelial growth factor (VEGF) by western blot. Our results (Figure 4.12) showed 
that VEGF expression was significantly reduced in the cells treated with ginger oil at 
concentrations of 0.05% and 0.1%. VEGF is a dimeric glycoprotein, which is the most important 
growth factor for inducing angiogenesis. High level of VEGF is associated with high malignancy 
and poor prognosis in cases of breast cancer (Shibata et al. 2002; Heffelfinger and others 1999). 
Angiogenesis is regulated by many molecules and VEGF being one of the very important one. It 







Figure 4.11: Inhibitory Effect of Ginger Oil on in-vitro Angiogenesis Tube Formation. A: Tubes 
Formed by Human Coronary Artery Endothelial Cells (HCAECs). B: Aligned 
HCAECs for Tube Formation in Presence of Media from Untreated Cells. C: 
Disrupted HCAECs in Presence of the Media from 0.05% GO. D: Disrupted 






physiological cases like wound healing and embryonic development and in pathological cases 
like cancer. In case of cancer, when a tumor cannot grow beyond a certain size, it starts secreting 
VEGF molecules. VEGF receptors are present in endothelial cells, once VEGF molecule binds 
itself with these receptors, the physiological response of endothelial cell changes, directing the 
growth of blood vessels towards the tumor, eventually supplying nutrients and oxygen. 
4.8.2.2 Phospho-erk 
Phospho-erk is one of the major biomarker of signalling events for monitoring 
angiogenesis (Sessa and others 2008) and is the down streaming molecule in MAPK pathway . 
The intracellular signaling cascade involving MAPK /ERK leads to anti-apoptotic pathway and 
stimulates growth signals (Stuart and others 2006).  As shown in figure 4.12, the results of the 
treatment of MDA-MB-231 cells with ginger oil showed inhibition of phosphorylated ERK when 
compared with the control. 
 
4.8.2.3 Cathepsin D  
Our results show that MDA-MB-231 cells treated with ginger oil had reduced level of 
cathepsin D expression. The result is shown in figure 4.12. Cathepsin D is an acidic lysosomal 
aspartyl endoprotease and is considered one of the biomarkers of breast cancer. It is reported to 
be overexpressed in pathological condition and is responsible for malignancy. Evidences suggest 
that the expression of cathepsin D is increased by 2 to 50 times in breast cancer cells as 
compared to normal mammary cells or other cells (Capony and others 1989). It plays role in cell 
proliferation, apoptosis, extra cellular matrix degradation, activation of growth factors, and 
angiogenesis (Leto and others 2004). Literatures suggest that cathepsin D in breast cancer cells, 
boosts anchorage-independent cell proliferation leading to tumorigenesis and metastasis (Glondu 
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and others 2002).  Cathepsin is supposed to be up regualted and heavily secreted in ER negative 
MDA-MB-231 cells (Garcia and others 1996). Literatures suggest that MDA-MB-231 cells are 
model of breast cancer cells with high cathepsin D level with more metastatic properties, which 
makes cathepsin D a potential target for breast cancer therapy (Rochefort and others 2000).   
4.8.2.4 Histone Deacetylases (HDACs) 
As shown in figure 4.12, HDACs are down regulated with the treatment of ginger oil. 
HDACs are the enzymes involved in epigenetics, most commonly in DNA methylation and 
acetylation. It controls most of the genes responsible for angiogenesis, cell cycle, and apoptosis 
(Shankar and Srivastava 2008). Also histone deacetylase have been reported to induce apoptosis 
by up regulating the pro-apoptotic proteins and inhibiting the anti- apoptotic proteins. Histone 
inhibitors have also been reported to reduce the level of VEGF expression in tumor cells of mice 
(Shankar and others 2005).  
 
Figure 4.12: Expression of angiogenic biomarkers 
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4.8.3 Effect of Ginger Oil on Interleukin-8 (IL-8) Levels 
To determine the level of expression of IL-8, ELISA was performed. IL-8 is produced 
mostly by monocytes, macrophages, T cells and vascular endothelial cells. Its secretion is 
regulated by NFκB. IL-8 is reported to function in formation of new micro vessels, tumor 
neovascularization, help in tumor growth and metastasis, and activate the ERK2/1 pathway 
(Heidemann and others 2003).   It has also been found out that the level of IL-8 expression 
increases with decrease in the level of estrogen receptor. IL-8 is one of the major molecules 
found to be responsible for the properties like invasion and angiogenesis in breast cancer (Lin 
and others 2004). Dietary agents such as curcumin, querectin, resveratrol, genistein, green tea 
polyphenols, theaflavin, and capsaicin has been reported to down regulate the expression of IL-8 
(Hidaka and others 2002; Shen and others 2003; Porath and others 2005). Literatures show that 
ginger is able to inhibit the expression of IL-8 in ovarian cancer cells (Rhode and others 2007). 
Another group of researchers have shown that ginger extract at a concentration of 100µg/ml was 
able to inhibit the expression of chemokines in human synoviocytes (Phan and others 2005). 
Researches have shown that ginger can effectively modulate the biochemical pathway in chronic 
inflammation with changing expression of various chemokines and cytokines genes including 
cyclooxygenase-2 (Grzanna et al. 2005) . 
In our study we have used MDA-MB-231 cell line, which is ER
-
 and according to the 
findings of Lin et al. as mentioned above the level of IL-8 expression is high in ER
-
 cells. And 
this level of IL-8 was significantly dose dependently decreased in the cells treated with 0.05% 





Figure 4.13: Dose Dependent Inhibition of Ginger Oil on the Expression of Interleukin-8 (IL-8). 











































CHAPTER 5: SUMMARY AND CONCLUSIONS 
Data accumulated from this research propose that dietary phytochemicals, like ginger oil 
have the potential to manage deregulated signaling pathways or restore checkpoint pathways and 
apoptosis in cancer. Biological activities of ginger oil show promising future in treatment of 
cancer. However, this requires further investigation to figure out mode of action of ginger oil and 
additional research to determine the amount of regular intake. 
In summary, the major finding of this study is that ginger oil inhibits the viability of 
breast cancer cells through caspase-mediated pathway, as well as down regulates Hsp90 and its 
related client proteins. Ginger Oil induced apoptosis with the increase in caspase activity, cell 
cycle arrest in the S-phase and increase in the level of sub-G1 phase. Ginger oil also decreased 
protein levels of cyclin D1, cyclin dependent kinase (Cdk)-2, Cdk-4 and Bcl-2 level while it 
increased the level of apoptotic proteins such as Bax. In addition, ginger oil inhibited in vitro 
angiogenesis and biomarkers associated with angiogenesis. Ginger oil also significantly reduced 
the expression of various oncoproteins and repressed the activity of telomerase that are expressed 
in breast cancer cells. Hence, ginger oil is an essential oil with various anti-cancer properties.  So 
far we have demonstrated that ginger oil inhibits hallmarks of breast cancer cells, however, it 
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